14.12 USD
↗ 0.31 (2.25%)AT CLOSE (11:59 AM EDT)
Vor Biopharma Inc. Common Stock
VORNASDAQ • USD
14.21
↗ 0.09 (0.64%)
POST MARKET (AS OF 06:47 PM EDT)
Post Market
AS OF 06:47 PM EDT
14.21
↗ 0.09 (0.64%)
Market: CLOSED
Open?$13.82
High?$14.59
Low?$13.77
Prev. Close?$13.81
Volume?1.1M
Avg. Volume?1.3M
VWAP?$14.09
Rel. Volume?0.83x
Bid / Ask
Bid?$11.95 × 100
Ask?$16.10 × 100
Spread?$4.15
Midpoint?$14.03
Valuation & Ratios
Market Cap?674.6M
Shares Out?48.8M
Float?29.2M
Float %?70.3%
P/E Ratio?N/A
P/B Ratio?-4.11
EPS?-$14.25
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?18.20Strong
Quick Ratio?18.20Strong
Cash Ratio?15.75Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?-4.11CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.8CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?423.6%STRONG▾
ROA?-150.0%WEAK▾
Cash Flow & Enterprise
FCF?$-143654000
Enterprise Value?$278.1M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Employees
168
Market Cap
674.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-02-05
Address
500 BOYLSTON STREET
BOSTON, MA 02116
Phone: 617-655-6580
BOSTON, MA 02116
Phone: 617-655-6580